# Why Bitcoin for Canurta

By [Canurta.eth](https://paragraph.com/@canurta) · 2025-05-24

---

_By Akeem Gardner, CEO & Founder, Canurta Therapeutics_

![](https://storage.googleapis.com/papyrus_images/e187fbb0e1cacac9bbf95e1147c0c5189327d138865e9cb47233b7254b1c710a.jpg)

At Canurta, we’ve never followed convention for convention’s sake. We’re building a new blueprint for how biotech companies can scale — one that prioritizes financial resilience, founder-led execution, and long-term shareholder value. That’s why we’re anchoring our capital strategy to Bitcoin.

This is not a gimmick. It’s a deliberate financial move that increases our purchasing and R&D power by 30–60% ARR and positions us to lead institutional biotech innovation in Canada with asymmetric upside and limited downside. We're creating the first adaptive medicine company backed by Bitcoin reserves — and with it, a new playbook for the capital markets.

### **Why Bitcoin**

_Strengthens Capital Efficiency_

By integrating Bitcoin into our treasury model:

*   We gain exposure to an appreciating reserve asset
    
*   We minimize dilution by accessing BTC-backed financing tools
    
*   We enable strategic rebalancing to meet investor needs during volatility
    

_Enables Optionality Without Fragility_

With regulated Canadian OTC access and margin lending partners, we can:

*   Sell or collateralize BTC as needed, without relying on banks
    
*   Fund trials, operations, or acquisitions with non-dilutive capital
    
*   Maintain a steady NAV anchor (3:1) to issue optional securities if desired
    

_Aligns with Institutional Trends_

With FASB guidance and growing institutional adoption, BTC is no longer fringe — it’s part of the future. This gives Canurta a chance to front-run a shift in capital formation and stand out as an institutional-grade biotech that operates with the prudence of a sovereign investor.

### **Rethinking Risk**

As Warren Buffett said:

> “Risk is not volatility, but permanent loss of capital.”

We agree. Volatility is not the enemy — poor execution is.

Bitcoin offers volatility, yes — but also resilience, transparency, and global liquidity. By contrast, the permanent loss of purchasing power in fiat currencies, especially the USD, is the silent risk that most overlook.

### **What It Takes to Win**

Executing a strategy like this requires:

*   **Courage from the founder**
    
*   **Goodwill from the team**
    
*   **Trust from our investors**
    

And most importantly: **results.** We're not asking to be believed — we're asking to be measured. Canurta’s team is here to execute.

### **The Broader Vision: Advancing Canadian Capital Markets**

Our ambition goes beyond Canurta. We believe Canada can be a global leader in BTC-backed biotech finance. We're building this strategy not just for ourselves, but for:

*   CanadianMunicipalities, like Vancouver, with forward-thinking financial structures
    
*   Corporations and SMEs looking to access resilient, modern capital
    
*   Boards of Trade and innovation councils who can champion resilient business models across the country
    

This isn’t theory — it’s a testable, repeatable path. One step at a time, using open-source tools, transparency, and results.

### **The “Holy Grail” of Finance: Uncorrelated Alpha**

Bitcoin gives us what traditional portfolios struggle to find: _An uncorrelated asset that improves risk-adjusted returns._

We manage volatility through:

*   Position sizing and drawdown strategies
    
*   Keeping our mind on long time horizons that allow us to ride macro cycles
    
*   Quarterly rebalancing and capital rotation discipline
    

### **Closing Thought**

Markets reward clarity and courage.We’re not chasing trends — we’re setting the terms.

BTC gives Canurta the freedom to execute without surrendering control. It strengthens our balance sheet, hedges systemic risk, and creates a durable advantage for our shareholders — one that compounds over time.

We're not here to play defense. We're here to win.

Let’s build the future of medicine — backed by the future of money.

Akeem Gardner | CEO & Founder | Canurta Therapeutics | [akeem@canurta.com](mailto:akeem@canurta.com)

---

*Originally published on [Canurta.eth](https://paragraph.com/@canurta/why-bitcoin-for-canurta)*